SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-194381
Filing Date
2009-09-18
Accepted
2009-09-18 16:02:01
Documents
5
Period of Report
2009-09-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14304
2 PRESS RELEASE dex991.htm EX-99.1 5393
3 PRESS RELEASE dex992.htm EX-99.2 5453
4 GRAPHIC g23745g07n62.jpg GRAPHIC 8124
5 GRAPHIC g23745g58i21.jpg GRAPHIC 7974
  Complete submission text file 0001193125-09-194381.txt   49232
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 091076923
SIC: 2836 Biological Products, (No Diagnostic Substances)